gip/glp-1 ra Tirzepatide's Unique Mechanism of Action GLP-1 & GIP Agonists |

These two approaches were applied to produce visual representations of body size and shape in Surmount 1 average male and female participants (maximal-tolerated dose group) at baseline and after 72-weeks of tirzepatide treatment

Reduo do apetite

GLP-1/PYY ( hunger) signal to the hypothalamus' arcuate nucleus

Bruising at injection sites is a common side effect of semaglutide therapy, occurring in approximately 10-15% of patients during their first month

See possible effects, side effects, and when to avoid it with meds or pregnancy.

Oral semaglutide offers a needle-free alternative for weight loss, with clinical trials demonstrating effectiveness comparable to injections